Lotteries

Lotte Biologics is a global contract development and manufacturing organization (CDMO) and a subsidiary of the South Korean conglomerate Lotte Group. Established in 2022, the company entered the biopharmaceutical market through the acquisition of Bristol Myers Squibb's manufacturing facility in Syracuse, New York. Lotte Biologics provides end-to-end services for the development and production of biologics, including monoclonal antibodies and antibody-drug conjugates (ADCs). The company is currently expanding its global footprint with the construction of a large-scale 'Mega Plant' in Songdo, South Korea, aimed at providing significant capacity for clinical and commercial production. Its business model focuses on high-quality manufacturing standards and strategic partnerships with global pharmaceutical firms.